Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,134,989
-$2,730,412 QoQ
Shares Held
87,426
-28.5% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 282 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $344,568,608 across 24 Biotechnology names. BNTX ranks #16 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
143,881 | $71,470,008 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,332 | $40,737,114 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
111,381 | $20,859,433 | |
| 4 | TECH |
BIO-TECHNE Corp
|
293,165 | $20,712,105 | |
| 5 | ARGX |
Argenx SE
|
22,193 | $20,589,999 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
58,666 | $17,660,224 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
307,103 | $17,572,433 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
55,002 | $15,673,919 |
All Filings in BNTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,134,989 | 87,426 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,865,401 | 122,248 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,841,395 | 103,376 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,090,804 | 112,460 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $12,775,015 | 119,987 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,987,299 | 120,660 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,493,730 | 118,418 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $11,245,737 | 94,685 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $9,635,244 | 119,901 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $10,858,655 | 117,709 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $11,471,775 | 108,696 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $13,690,160 | 126,014 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $14,247,514 | 132,007 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $17,021,991 | 136,646 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $22,484,328 | 149,676 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $16,719,859 | 123,961 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $20,143,111 | 135,098 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $24,411,740 | 143,127 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $23,637,682 | 91,690 | Shares | Defined | 2022-01-26 | |
| 2021-09-30 | $23,987,630 | 87,870 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $23,373,743 | 104,403 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $14,379,340 | 131,691 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $12,754,130 | 156,454 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $7,716,929 | 111,468 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||